Related Experiment Video
Updated: Oct 7, 2026

Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry
Published on: January 19, 2020
Cerebral perfusion in hypertensive patients: effects of lacidipine and hydrochlorothiazide
A Semplicini1, A Maresca, C Simonella
1Department of Clinical and Experimental Medicine, University of Padua, Italy.
Insights
Hypertension can cause uneven cerebral blood flow, particularly with white matter lesions or lacunae. Antihypertensive treatments like lacidipine and hydrochlorothiazide can improve this cerebral hypoperfusion.
Area of Science:
- Neurology
- Cardiology
- Radiology
Background:
- Asymptomatic hypertensives can exhibit cerebral hypoperfusion in frontal and parietal lobes.
- Cerebral hypoperfusion may occur without extracranial carotid artery stenosis.
Purpose of the Study:
- Correlate focal cortical hypoperfusion with white matter lesions (WML), lacunae, and carotid artery stenosis.
- Compare the effects of lacidipine and hydrochlorothiazide (HCTZ) on cerebral perfusion in hypertensive patients with carotid artery stenosis.
Main Methods:
- Investigated 41 hypertensive patients (aged 40-75) with varying degrees of carotid artery stenosis and cerebral lesions (WML, lacunae) using CT and SPET.
- Conducted a double-blind, randomized study comparing lacidipine and HCTZ in 15 hypertensive patients with moderate internal carotid artery (ICA) stenosis.
Main Results:
- Lesion prevalence was higher in patients with carotid artery stenosis (44% vs. 29%).
- Mean relative cortical perfusion (MRCP) was reduced in patients with lacunae and showed greater asymmetry in those with lacunar infarctions and WML.
- Both lacidipine and HCTZ increased MRCP and reduced local cerebral vascular resistance, with a greater reduction observed with lacidipine.
Conclusions:
- Cerebral blood flow distribution is uneven in hypertensive patients, especially with asymptomatic subcortical lesions, independent of ICA stenosis.
- Antihypertensive treatments with lacidipine and HCTZ can correct focal hypoperfusion and reduce cerebral vascular resistance without inducing steal effects in patients with ICA stenosis.
Abstract:
Previous studies have shown areas of cerebral hypoperfusion in the frontal and parietal lobes of asymptomatic hypertensives, in the absence of extracranial carotid artery stenosis. The aims of the present study were: (a) to correlate the presence of focal cortical hypoperfusion with the presence of white matter lesions (WML), lacunae and extracranial carotid artery stenosis; and (b) to compare the effects on cerebral perfusion of the dihydropyridine calcium entry blocker lacidipine and of hydrochlorothiazide (HCTZ) in hypertensive patients with carotid artery stenosis. Forty-one patients (30 males, aged 40-75) with mild to moderate essential hypertension and with negative history for cerebrovascular diseases were investigated. Twenty-four had normal extracranial carotid arteries at echo-colourDoppler examination, while 17 had at least one 50-70% stenosis of the internal carotid artery (ICA). At computed tomography (CT) scan, five patients had one or more lacunar infarctions, four WML, three lacunar infarctions and WML, and 26 a normal CT scan. Three, with old cortical infarctions, were excluded from further analysis. The prevalence of lesions was significantly higher among the patients with carotid artery stenosis (44% vs. 29%; p < 0.05). Distribution of mean relative cortical perfusion (MRCP) of regions of interest [hexamethyl-propileneamine oxime-single photon emission tomography (SPET)] was not normal, with a negative skewness in patients with lacunae. MRCP was slightly but significantly reduced in patients with lacunae in comparison with hypertensives with normal CT scan and with WML. The asymmetry index of tracer distribution was significantly greater in the patients with lacunar infarctions and WML than in the hypertensive patients with normal CT scan, irrespective of the presence of internal carotid artery stenosis. Fifteen hypertensives (13 males, aged 55-75 years) with at least one moderate stenosis of ICA at duplex scanning were treated in a double-blind, randomised, parallel study with lacidipine (4-6 mg o.d.) or HCTZ (25-50 mg o.d.) for 3 months after a 4-week single-blind placebo period. At baseline, perfusion of the cortical and basal areas was similar in the stenotic and the contralateral side. Despite the fall in pressure, both treatments increased MRCP in the stenotic side and in the contralateral side. The lower the baseline perfusion, the larger its increase with treatment. The decrease of local cerebral vascular resistance was significantly greater with lacidipine than with HCTZ. We conclude that in hypertensive patients, the distribution of cerebral flow is uneven, mostly in the presence of small asymptomatic subcortical lesions and independently from internal carotid artery stenosis. Antihypertensive treatment with lacidipine and HCTZ reduces local cerebral resistance and corrects focal hypoperfusion without inducing steal effects in patients with ICA stenosis.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Action of Diuretics
Increased Intracranial Pressure l: Introduction
Local Anesthetics: Pharmacokinetics

